Precision Biologics, Inc. CEO to present at the online Antibody-Drug Conjugates MicroSummit conference, March 17th, 2026.

Philip M. Arlen, M.D., will present an online talk at the third and last session of the Antibody-Drug Conjugates MicroSummit, entitled “Design and Development of a tumor-specific antibody-drug conjugate.” 

• Antibody-Drug Conjugates MicroSummit 
• From smarter design to safer Targeted Therapies 
• Quarter 1: Session 3 
• Date: March 17, 2026  
• Time: 1:00 PM – 2:00 PM (Eastern US)